Avalo Therapeutics Files Q1 2025 10-Q
Ticker: AVTX · Form: 10-Q · Filed: May 12, 2025 · CIK: 1534120
| Field | Detail |
|---|---|
| Company | Avalo Therapeutics, INC. (AVTX) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
Related Tickers: AVTX
TL;DR
Avalo Therapeutics (AVTX) filed its Q1 2025 10-Q. Financials are in.
AI Summary
Avalo Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Cerecor Inc., is based in Wayne, PA. The filing details its financial position and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with an update on Avalo Therapeutics' financial health and operational status for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Avalo Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 20250512 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Avalo Therapeutics, Inc. (company) — Filer of the 10-Q
- Cerecor Inc. (company) — Former name of Avalo Therapeutics
- 20250331 (date) — End of reporting period
- 20250512 (date) — Filing date
- Wayne, PA (location) — Business address
FAQ
What is the primary business of Avalo Therapeutics, Inc.?
Avalo Therapeutics, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the company formerly known as Cerecor Inc.?
The company changed its name from Cerecor Inc. on November 2, 2011.
What is the business address of Avalo Therapeutics?
The business address is 1500 Liberty Ridge Drive, Suite 321, Wayne, PA 19087.
What fiscal period does this 10-Q filing cover?
This 10-Q filing covers the fiscal period ending March 31, 2025.
What is the SEC file number for Avalo Therapeutics?
The SEC file number for Avalo Therapeutics is 001-37590.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Avalo Therapeutics, Inc. (AVTX).